Telbivudine CAS 3424-98-4 Purity ≥99.0% (HPLC) HBV Replication Inhibitor Factory

Short Description:

Chemical Name: Telbivudine

Synonyms: 2′-Deoxy-L-Thymidine 

CAS: 3424-98-4

Purity: ≥99.0% (HPLC)

Appearance: White Fine Powder 

Antiviral Inhibitor of Hepatitis B Virus (HBV) Replication

Contact: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

3424-98-4 - Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of Telbivudine (2'-Deoxy-L-Thymidine) (CAS: 3424-98-4) with high quality. Telbivudine, an orally active thymidine nucleoside analog, is a potent antiviral inhibitor of hepatitis B virus (HBV) replication. Ruifu Chemical has been supplying pharmaceutical intermediates and APIs, fine chemicals more than 15 years. Ruifu Chemical can provide worldwide delivery, competitive price, excellent service. Purchase Telbivudine or other products, please contact us by e-mail: alvin@ruifuchem.com

3424-98-4 - Chemical Properties:

Chemical Name Telbivudine 
Synonyms 2'-Deoxy-L-Thymidine; L-Thymidine; beta-L-Thymidine; β-L-Thymidine;  Epavudine; NV 02B; Sebivo; 1-(2-Deoxy-β-L-Erythro-Pentofuranosyl)-5-Methyl-2,4(1H,3H)-Pyrimidinedione; 1-[(2S,4R,5S)-4-Hydroxy-5-(Hydroxymethyl)tetrahydrofuran-2-yl]-5-Methylpyrimidine-2,4(1H,3H)-Dione
Stock Status In Stock, Production Capacity 15 Tons per Year
CAS Number 3424-98-4
Molecular Formula C10H14N2O5
Molecular Weight 242.23 g/mol
Melting Point 185.0~190.0℃ 
Density 1.452±0.06 g/cm3 
Store Under Inert Gas Store Under Inert Gas
Sensitive Air Sensitive, Heat Sensitive 
Solubility H2O Soluble 10mg/mL (Clear Solution) 
Storage Temp.  Store Long-term at 2~8℃ 
COA & MSDS Available
Origin of Product    Shanghai, China
Product Categories
API (Active Pharmaceutical Ingredient); Antiviral Agents
Caution Not Intended for Human Use. For Research Use Only.
Brand Ruifu Chemical

3424-98-4 - Specifications:

Items Specifications  Results
Appearance White Fine Powder   White Fine Powder    
Solubility Clear, Colorless in Water/Very Slightly Soluble Conforms
Identify (H NMR) Conforms to Structure Conforms
Melting Point 185.0~190.0℃ 186.0~188.0℃
Specific Rotation [α]20/D -19.0° ~ -17.0° (C = 1 in H2O) -18.4°
Loss on Drying ≤0.50% 0.12%
Residue on Ignition ≤0.20% Conforms  
Heavy Metals (Pb) ≤10ppm <10ppm 
Largest Impurities ≤0.30% 0.04%
Telbivudine Purity  >99.0% (HPLC)  99.9%
Conclusion The product has been tested and complies with the given specifications
Application A Potent Antiviral Inhibitor of Hepatitis B Virus (HBV) Replication

3424-98-4 - Package/Storage/Shipping:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry (2~8℃), well-ventilated warehouse away from incompatible substances. Keep away from sunshine; avoid fire and heat sources; avoid moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery. 

3424-98-4 - Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

3424-98-4 - FAQ:

How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.

Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.

Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory AuditFactory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

TransportationBy Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom SynthesisCan provide custom synthesis services to best fit your research needs.

Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

3424-98-4 - Risk and Safety:

Hazard Symbols Xn - Harmful 
Risk Codes 22 - Harmful if swallowed
Safety Description 24/25 - Avoid contact with skin and eyes.             
WGK Germany 3
RTECS UV9048500
HS Code 2934993090

3424-98-4 - Introduction:

Telbivudine (2'-Deoxy-L-Thymidine) (CAS: 3424-98-4) is a β-L-thymidine nucleoside analog launched for the once-daily oral treatment of chronic hepatitis B virus (HBV) infection. It is the fourth nucleoside or nucleotide analog to be marketed for this indication. The previous drugs from this class include lamivudine, a deoxythiacytosine analog, adefovir, a nucleotide analog, and entecavir, a guanosine analog. Adefovir, entecavir, and telbivudine are specifically indicated for HBV, whereas lamivudine is indicated for both HBV and HIV infections. Telbivudine is efficiently phosphorylated by cellular kinases to the active triphosphate derivative, which inhibits HBV DNA polymerase by competing with the natural substrate, thymidine- 5'-triphosphate.

3424-98-4 - Application:

Telbivudine (2'-Deoxy-L-Thymidine) (CAS: 3424-98-4) is an antiviral drug used in the treatment of hepatitis B virus (HBV) infection. Clinical trials have shown it to be significantly more effective than Lamivudine or Adefovir, and less likely to cause resistance. For the treatment of chronic hepatitis B in adult and adolescent patients ≥16 years of age with evidence of viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.

  • Write your message here and send it to us